Back to Journals » Oncolytic Virotherapy » Volume 8

Oncolytic Virotherapy

Archive: Volume 8, 2019

Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma Virus

Burton C, Bartee MY, Bartee E

Oncolytic Virotherapy 2019, 8:57-69

Published Date: 9 December 2019

Virus–Receptor Interactions: Structural Insights For Oncolytic Virus Development

Jayawardena N, Burga LN, Poirier JT, Bostina M

Oncolytic Virotherapy 2019, 8:39-56

Published Date: 29 October 2019

Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes

Zainutdinov SS, Kochneva GV, Netesov SV, Chumakov PM, Matveeva OV

Oncolytic Virotherapy 2019, 8:9-26

Published Date: 12 July 2019

A cautionary note on the selectivity of oncolytic poxviruses

Tang B, Guo ZS, Bartlett DL, Liu J, McFadden G, Shisler JL, Roy EJ

Oncolytic Virotherapy 2019, 8:3-8

Published Date: 11 February 2019

Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma [Corrigendum]

Babiker HM, Riaz IR, Husnain M, Borad MJ

Oncolytic Virotherapy 2019, 8:1-2

Published Date: 4 January 2019